Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Supporting your high street Find out how »
Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System : Workshop Summary, Paperback / softback Book

Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System : Workshop Summary Paperback / softback

Edited by Bruce M. Altevogt, Miriam Davis, Diana E. Pankevich

Paperback / softback

Available to Order - This title is available to order, with delivery expected within 2 weeks

Description

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS).

Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries.

Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders.

Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury.

These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat.

Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers.

The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders.

Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.

Information

Other Formats

Save 1%

£17.99

£17.65

Available to Order - This title is available to order, with delivery expected within 2 weeks
Add to Basket
Sign in to add to wishlist
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information